229 related articles for article (PubMed ID: 33307595)
1. Diagnostic Accuracy of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for Differentiating Between Hepatocellular Carcinoma and Other Hepatic Malignancies in High-Risk Patients: A Meta-Analysis.
Li J; Yang L; Ma L; Lu Q; Luo Y
Ultraschall Med; 2021 Apr; 42(2):187-193. PubMed ID: 33307595
[TBL] [Abstract][Full Text] [Related]
2. MR versus CEUS LI-RADS for Distinguishing Hepatocellular Carcinoma from other Hepatic Malignancies in High-Risk Patients.
Huang Z; Zhou P; Li S; Li K
Ultrasound Med Biol; 2021 May; 47(5):1244-1252. PubMed ID: 33610338
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification for hepatocellular carcinoma of contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) and the diagnostic performance of LR-5 and LR-M: a systematic review and meta-analysis.
Qin Z; Zhou Y; Ding J; Wen J; Chen Y; Zhou H; Jing X
Clin Radiol; 2022 Apr; 77(4):e280-e286. PubMed ID: 35164930
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma.
Li S; Zhou L; Chen R; Chen Y; Niu Z; Qian L; Fang Y; Xu L; Xu H; Zhang L
Clin Radiol; 2021 Feb; 76(2):161.e1-161.e10. PubMed ID: 33198943
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound liver imaging reporting and data system for diagnosing hepatocellular carcinoma: A meta-analysis.
Shin J; Lee S; Bae H; Chung YE; Choi JY; Huh YM; Park MS
Liver Int; 2020 Oct; 40(10):2345-2352. PubMed ID: 32722894
[TBL] [Abstract][Full Text] [Related]
8. Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?-a direct head-to-head meta-analysis.
Wang H; Cao J; Fan H; Huang J; Zhang H; Ling W
Quant Imaging Med Surg; 2023 Aug; 13(8):4919-4932. PubMed ID: 37581040
[TBL] [Abstract][Full Text] [Related]
9. Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
Li L; Zheng W; Wang J; Han J; Guo Z; Hu Y; Li X; Zhou J
AJR Am J Roentgenol; 2022 Sep; 219(3):434-443. PubMed ID: 35441534
[No Abstract] [Full Text] [Related]
10. The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system.
Li J; Ling W; Chen S; Ma L; Yang L; Lu Q; Luo Y
Eur J Radiol; 2019 Nov; 120():108685. PubMed ID: 31606712
[TBL] [Abstract][Full Text] [Related]
11. Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC.
Wen R; Huang W; Song R; Qin L; Wu Y; Peng Y; Huang X; He Y; Yang H
BMC Med Imaging; 2023 Sep; 23(1):122. PubMed ID: 37697248
[TBL] [Abstract][Full Text] [Related]
12. The Value of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
Peng J; Zhang T; Wang H; Ma X
J Ultrasound Med; 2022 Jun; 41(6):1537-1547. PubMed ID: 34617296
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F
Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416
[TBL] [Abstract][Full Text] [Related]
14. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
15. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
[TBL] [Abstract][Full Text] [Related]
16. Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS.
Chen LD; Ruan SM; Lin Y; Liang JY; Shen SL; Hu HT; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
Eur Radiol; 2019 Aug; 29(8):4249-4257. PubMed ID: 30569182
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of modified contrast-enhanced ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) using Sonazoid in diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
Liu Q; Liu T; Liu X; Zhang F; Yang J; Cheng Y; Yang Q
Quant Imaging Med Surg; 2024 Apr; 14(4):2927-2937. PubMed ID: 38617149
[TBL] [Abstract][Full Text] [Related]
18. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of contrast-enhanced ultrasound liver imaging reporting and data system: a systematic review and meta-analysis.
Son JH; Choi SH; Kim SY; Lee SJ; Park SH; Kim KW; Won HJ; Shin YM; Kim PN
Hepatol Int; 2020 Dec; 14(6):1104-1113. PubMed ID: 33170416
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of Modified Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Patients Without Risk Factors for Hepatocellular Carcinoma: Comparison With World Federation for Ultrasound in Medicine and Biology Guideline.
Zhang Y; Li Q; Li L; Hong Y; Qiang B; Yu Y; Guo R; Deng H; Han X; Zou X; Guo Z; Zhou J
Ultrasound Med Biol; 2024 Feb; 50(2):243-250. PubMed ID: 37985306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
